CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. (Q53370464)

13 May 2018

title

CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells. (English)

1 reference

13 May 2018

author name string

D Kim

1

1 reference

13 May 2018

C Y Park

2

1 reference

13 May 2018

B C Medeiros

3

1 reference

13 May 2018

I L Weissman

4

1 reference

13 May 2018

publication date

30 May 2012

1 reference

13 May 2018

published in

Leukemia

1 reference

13 May 2018

volume

26

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

page(s)

2530-2537

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2012.140

exact match

0 references

cites work

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Phenotypic heterogeneity and instability of human ovarian tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Identification of gastric cancer stem cells using the cell surface marker CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Characterization of clonogenic multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

In vivo evaluation of human hematopoiesis through xenotransplantation of purified hematopoietic stem cells from umbilical cord blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma: a potential in vivo culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

First among equals: the cancer cell hierarchy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Development of a human adaptive immune system in cord blood cell-transplanted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

A crosstalk between myeloma cells and marrow stromal cells stimulates production of DKK1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Memory T and memory B cells share a transcriptional program of self-renewal with long-term hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Stem cell research: paths to cancer therapies and regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

7 January 2021

The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

7 January 2021

Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

7 January 2021

Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

7 January 2021

CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.140

7 January 2021

Identifiers

DOI

10.1038/LEU.2012.140

1 reference

13 May 2018

PubMed ID

22733078

1 reference

13 May 2018